Attention‐deficit/hyperactivity disorder in neurofibromatosis type 1
Developmental Medicine & Child Neurology · 29.07.2026
DOI: 10.1111/dmcn.70423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 29.07.2026. Verfasst von Yang Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee, FL, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, Florida State University, University of Kentucky.
Abstract (Originalsprache)
Aim
To characterize age‐specific patterns of attention‐deficit/hyperactivity disorder (ADHD) symptoms and identify symptom profiles, as well as their associations with demographic and disease‐specific factors, in a large international sample of children with neurofibromatosis type 1 (NF1).
Method
Observational data from 904 assessments in 656 children with NF1 (age mean [SD] 9 years 6 months [3 years 11 months]; range 3–18 years; 43.4% female) across eight institutions were pooled. With a cross‐sectional design, age‐varying ADHD symptom patterns were examined using time‐varying effect modeling; latent profile analysis was used to classify symptom profiles.
Results
Across ages 3 to 17 years, children with NF1 showed elevated inattention and hyperactivity/impulsivity relative to the normative mean, with inverted U‐shaped age patterns peaking around age 10 years. Four ADHD profiles emerged: typical range ( n = 416; 46.0%); severe combined ( n = 199; 22.0%); mild combined ( n = 181; 20.0%); and predominantly inattentive ( n = 108; 12.0%). Greater symptom severity was associated with female sex and lower parental education.
Interpretation
ADHD symptoms in children with NF1 were elevated across ages, with the greatest symptom burden in middle childhood, alongside substantial heterogeneity in symptom presentation. These findings underscore the need for early recognition, ongoing monitoring, and individualized interventions to mitigate long‐term academic, social, and functional impacts.
Autor:innen und Institutionen
- Department of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee, FL, USA.
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Department of Psychological and Brain Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
- Children's National Hospital, Washington, D.C, USA.
- The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
- University of Manchester & Manchester University Foundation NHS Trust, Manchester, UK.
ORCID-Profile: Bonita P Klein-Tasman, Karin S Walsh, Shruti Garg, Stephanie M Morris, Jonathan M Payne
Förderung
- Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research
- Florida State University
- University of Kentucky
- Congressionally Directed Medical Research Programs, Department of Defense
- Congressionally Directed Medical Research Programs
Zitieren
APA
Hou, Y., Song, J., Liu, D., Wolters, P. L., Klein-Tasman, B. P., Walsh, K. S., Pride, N. A., Garg, S., Morris, S. M., Gilboa, Y., & Payne, J. M. (2026). Attention‐deficit/hyperactivity disorder in neurofibromatosis type 1. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70423
Vancouver
Hou Y, Song J, Liu D, Wolters PL, Klein-Tasman BP, Walsh KS, et al. Attention‐deficit/hyperactivity disorder in neurofibromatosis type 1. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70423
BibTeX
@article{Hou2026,
author = {Hou, Yang and Song, Jiaxiu and Liu, Dan and Wolters, Pamela L and Klein-Tasman, Bonita P and Walsh, Karin S and Pride, Natalie A and Garg, Shruti and Morris, Stephanie M and Gilboa, Yafit and Payne, Jonathan M},
title = {Attention‐deficit/hyperactivity disorder in neurofibromatosis type 1},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70423}
}
EUVIMED